Public health officials, including FDA chief Stephen Hahn, are trying to tamp down concerns that the agency will lower its drug approval standards in efforts to get a COVID-19 vaccine and potential therapies to the public as fast as possible. The drug industry and FDA have been working quickly to develop, manufacture and assess vaccines for potential approval by early 2021, but the Trump administration on Thursday (Aug. 6) called for more regulatory flexibility. Hahn penned an op-ed in the...